amlodipine has been researched along with Rectal Neoplasms in 1 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
Rectal Neoplasms: Tumors or cancer of the RECTUM.
Excerpt | Relevance | Reference |
---|---|---|
"Regorafenib is a multikinase inhibitor." | 5.72 | Amlodipine improves the outcomes of regorafenib in metastatic colorectal cancer. ( Alandağ, C; Karaman, E; Yüce, E, 2022) |
"Regorafenib is a multikinase inhibitor." | 1.72 | Amlodipine improves the outcomes of regorafenib in metastatic colorectal cancer. ( Alandağ, C; Karaman, E; Yüce, E, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Alandağ, C | 1 |
Karaman, E | 1 |
Yüce, E | 1 |
1 other study available for amlodipine and Rectal Neoplasms
Article | Year |
---|---|
Amlodipine improves the outcomes of regorafenib in metastatic colorectal cancer.
Topics: Amlodipine; Colonic Neoplasms; Colorectal Neoplasms; Humans; Liver Neoplasms; Phenylurea Compounds; | 2022 |